167 related articles for article (PubMed ID: 22205939)
1. Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice.
Parra M; Derrick SC; Yang A; Tian J; Kolibab K; Oakley M; Perera LP; Jacobs WR; Kumar S; Morris SL
PLoS One; 2011; 6(12):e28164. PubMed ID: 22205939
[TBL] [Abstract][Full Text] [Related]
2. BCG-mediated protection against M. tuberculosis is sustained post-malaria infection independent of parasite virulence.
Tangie E; Walters A; Hsu NJ; Fisher M; Magez S; Jacobs M; Keeton R
Immunology; 2022 Feb; 165(2):219-233. PubMed ID: 34775598
[TBL] [Abstract][Full Text] [Related]
3. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis.
Derrick SC; Repique C; Snoy P; Yang AL; Morris S
Infect Immun; 2004 Mar; 72(3):1685-92. PubMed ID: 14977976
[TBL] [Abstract][Full Text] [Related]
4. Heterologous Boost Following
Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
Front Immunol; 2018; 9():2439. PubMed ID: 30425711
[TBL] [Abstract][Full Text] [Related]
5. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.
Derrick SC; Yabe IM; Yang A; Morris SL
Vaccine; 2011 Apr; 29(16):2902-9. PubMed ID: 21338678
[TBL] [Abstract][Full Text] [Related]
7. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination.
Parra M; Liu X; Derrick SC; Yang A; Tian J; Kolibab K; Kumar S; Morris SL
PLoS One; 2013; 8(7):e66115. PubMed ID: 23861742
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.
Page KR; Jedlicka AE; Fakheri B; Noland GS; Kesavan AK; Scott AL; Kumar N; Manabe YC
Infect Immun; 2005 Dec; 73(12):8369-80. PubMed ID: 16299335
[TBL] [Abstract][Full Text] [Related]
10. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
[TBL] [Abstract][Full Text] [Related]
11. Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.
Kolibab K; Yang A; Derrick SC; Waldmann TA; Perera LP; Morris SL
Clin Vaccine Immunol; 2010 May; 17(5):793-801. PubMed ID: 20357059
[TBL] [Abstract][Full Text] [Related]
12. A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
Dey B; Jain R; Gupta UD; Katoch VM; Ramanathan VD; Tyagi AK
PLoS One; 2011; 6(8):e23360. PubMed ID: 21858087
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice.
Jeon BY; Derrick SC; Lim J; Kolibab K; Dheenadhayalan V; Yang AL; Kreiswirth B; Morris SL
Infect Immun; 2008 Nov; 76(11):5173-80. PubMed ID: 18710860
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.
Lu J; Wang C; Zhou Z; Zhang Y; Cao T; Shi C; Chen Z; Chen L; Cai C; Fan X
Clin Dev Immunol; 2011; 2011():617892. PubMed ID: 21461375
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.
Wu M; Zhao H; Li M; Yue Y; Xiong S; Xu W
Front Cell Infect Microbiol; 2017; 7():445. PubMed ID: 29085809
[TBL] [Abstract][Full Text] [Related]
16. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens.
Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S
Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890
[TBL] [Abstract][Full Text] [Related]
18. [Recent progress in mycobacteriology].
Okada M; Kobayashi K
Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
[TBL] [Abstract][Full Text] [Related]
19. One Episode of Self-Resolving Plasmodium yoelii Infection Transiently Exacerbates Chronic Mycobacterium tuberculosis Infection.
Blank J; Eggers L; Behrends J; Jacobs T; Schneider BE
Front Microbiol; 2016; 7():152. PubMed ID: 26913029
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis.
Delogu G; Li A; Repique C; Collins F; Morris SL
Infect Immun; 2002 Jan; 70(1):292-302. PubMed ID: 11748195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]